Lung cancer cells can go 'off grid' and develop their own electrical network within the tumor, study shows
Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...
PMLiVE5h
Boehringer’s nerandomilast shows promise in phase 3 pulmonary fibrosis study
Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...
United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...
Pharmabiz11h
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint: Ingelheim, Germany Wednesday, February 12, ...